Northern Trust
CLOV icon

Northern Trust’s Clover Health Investments CLOV Stock Holding History

Northern Trust’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8M Buy
3,772,600
+466,025
+14% +$1.58M ﹤0.01% 1814
2026
Q1 		$5.82M Buy
3,306,575
+128,145
+4% +$278K ﹤0.01% 2380
2025
Q4 		$7.47M Sell
3,178,430
-194,762
-6% -$532K ﹤0.01% 2237
2025
Q3 		$10.3M Sell
3,373,192
-2,819
-0.1% -$8.05K ﹤0.01% 2097
2025
Q2 		$9.42M Buy
3,376,011
+2,341,788
+226% +$7.7M ﹤0.01% 2108
2025
Q1 		$3.71M Sell
1,034,223
-51,403
-5% -$206K ﹤0.01% 2580
2024
Q4 		$3.42M Buy
1,085,626
+149,714
+16% +$535K ﹤0.01% 2734
2024
Q3 		$2.64M Buy
935,912
+240,317
+35% +$550K ﹤0.01% 2830
2024
Q2 		$856K Sell
695,595
-145,240
-17% -$130K ﹤0.01% 3312
2024
Q1 		$668K Sell
840,835
-37,441
-4% -$34.1K ﹤0.01% 3467
2023
Q4 		$836K Buy
878,276
+84,446
+11% +$82.9K ﹤0.01% 3374
2023
Q3 		$857K Buy
793,830
+66,590
+9% +$79.2K ﹤0.01% 3345
2023
Q2 		$652K Sell
727,240
-2,584,711
-78% -$2.29M ﹤0.01% 3478
2023
Q1 		$2.8M Sell
3,311,951
-161,706
-5% -$177K ﹤0.01% 2793
2022
Q4 		$3.23M Buy
3,473,657
+13,635
+0.4% +$18.2K ﹤0.01% 2740
2022
Q3 		$5.88M Sell
3,460,022
-142,416
-4% -$373K ﹤0.01% 2369
2022
Q2 		$7.71M Buy
3,602,438
+2,787,563
+342% +$7.41M ﹤0.01% 2231
2022
Q1 		$2.89M Sell
814,875
-16,107
-2% -$46.7K ﹤0.01% 2899
2021
Q4 		$3.09M Buy
830,982
+118,550
+17% +$727K ﹤0.01% 2991
2021
Q3 		$5.26M Buy
712,432
+455,109
+177% +$3.89M ﹤0.01% 2700
2021
Q2 		$3.43M Buy
257,323
+50,880
+25% +$500K ﹤0.01% 3061
2021
Q1 		$1.56M Buy
+206,443
New +$2.33M ﹤0.01% 3377

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust's CLOV Position: Q2 2026 in Review

Northern Trust increased its Clover Health Investments (CLOV) stake by 14% in Q2 2026, buying an estimated $1.58M and bringing the position to 3,772,600 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Northern Trust first reported a position in CLOV in Q1 2021 and has held it in 22 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Northern Trust held 3,772,600 shares of Clover Health Investments worth $19.8M as of Q2 2026.
  • Northern Trust bought 466,025 Clover Health Investments shares in Q2 2026, an estimated $1.58M.
  • Clover Health Investments made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1814 holding.
  • Northern Trust first reported a position in Clover Health Investments in Q1 2021 and has held it in 22 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.